08:00 , Mar 24, 2003 |  BC Week In Review  |  Company News

Biokeys management update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Cancer, Infectious diseases   Hired: Joan Robbins as CTO, formerly VP of product development at Immusol Inc.  ...
08:00 , Feb 17, 2003 |  BC Week In Review  |  Company News

Biokeys management update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Cancer, Infectious diseases   Hired: Steven Plumb as CFO, formerly an industry consultant  ...
08:00 , Jan 20, 2003 |  BC Week In Review  |  Company News

Biokeys board of directors update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Cancer, Infectious diseases   Resigned: Louis Reif, chairman of McCullough International Corp.  ...
08:00 , Dec 23, 2002 |  BC Week In Review  |  Company News

Biokeys management update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Infectious diseases   Resigned: Warren Lau as CFO and a director  ...
08:00 , Oct 28, 2002 |  BC Week In Review  |  Company News

Biokeys board of directors update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Infectious diseases   Appointed: M. Ross Johnson, former CEO of Trimeris Inc. , as chairman   Resigned: Robert Whitworth  ...
08:00 , Oct 28, 2002 |  BC Week In Review  |  Company News

Biokeys management update

Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   Business: Infectious diseases   Transition: Nicholas Virca to CEO and a director, while remaining CEO of BKYS's Biokeys Inc. subsidiary   Hired: Evan Levine as interim COO...
07:00 , Jul 15, 2002 |  BC Week In Review  |  Company News

Biokeys, National Institutes of Health deal

BKYS received from NIH an exclusive global sub-license to its U.S. Patent No. 5,562,905 covering an HIV viral entry inhibitor. Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif.   National Institutes of Health , Bethesda ,...
07:00 , Jul 30, 2001 |  BC Week In Review  |  Clinical News

HIV/AIDS peptide vaccine regulatory update

The University of Texas (Austin) received U.S. Patent No. 6,265,539 covering a peptide vaccine that stimulates cellular immunity to HIV. BKYS is the exclusive licensee of the patent. Biokeys Pharmaceuticals Inc. (BKYS), San Diego, Calif....
07:00 , Jun 18, 2001 |  BC Week In Review  |  Company News

Biokeys, University of Texas deal

BKYS and the university's M.D. Anderson Cancer Center expanded an existing licensing deal. As expanded, BKYS will receive a license to the center's patents covering an HIV vaccine and BKYS received the right of first...
08:00 , Jan 2, 2001 |  BC Week In Review  |  Company News

Biokeys, University of Southern California deal

BKYS obtained an exclusive worldwide license to the university's ThioChemistry combinatorial chemistry technology and the related Thiovir line of antiviral and anticancer compounds. BKYS will fund preclinical studies at USC of Thiovir and Thirovir analogs...